Nicholas J. Simmonds

Nicholas J. Simmonds

Auto-generated profile, based on publicly available information

Nicholas J. Simmonds

National Heart and Lung Institute, Imperial College London UK, Royal Brompton Hospital, part of Guy's and St Thomas' NHS Foundation Trust, London, UK

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2011 in BMJ
Verified
Journal Article
Open access
PDF file
PGP. M. George
P. M. George
WBW. Banya
W. Banya
NPN. Pareek
N. Pareek
DBD. Bilton
D. Bilton
PCP. Cullinan
P. Cullinan
NSN. J. Simmonds
N. J. Simmonds
Objectives To evaluate the survival of patients with cystic fibrosis whose lung function has deteriorated to a forced expiratory volume in one second (FEV1) below 30% predicted in the recent treatment era and to explore factors associated with any change in survival. Design Cohort study. Setting Adult cystic fibrosis unit in London. Participants 276 patients (147 (53%) male) whose FEV1 was first observed to be less than 30% predicted between 1 January 1990 and 31 December 2003. Main outcome measure Survival during follow-up to 31 December 2007 in two year sub-cohorts. Results Median survival improved from 1.2 years in the 1990-1 group to 5.3 years in the 2002-3 group, with a marked improvement in survival from 1994. The use of nebulised recombinant human DNase was significantly associated with a reduced risk of death (hazard ratio 0.59, 95% confidence interval 0.44 to 0.79). Significantly increased risks were associated with a body mass index under 19 (hazard ratio 1.52, 1.10 to 2.10), long term oxygen therapy (3.52, 2.49 to 4.99), and nebulised antibiotics (1.84, 1.05 to 3.22). Conclusion A marked improvement has occurred in the survival of patients with cystic fibrosis with an FEV1 less than 30% predicted. Secondary analyses suggest that some of this improvement may be due to use of recombinant human DNase.

1 March 2016 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
JBJuliana C. Burgess
Juliana C. Burgess
NBNicola Bridges
Nicola Bridges
WBWinston Banya
Winston Banya
KGKhin M. Gyi
Khin M. Gyi
MHMargaret E. Hodson
Margaret E. Hodson
NSNicholas J. Simmonds
Nicholas J. Simmonds

8 April 2010 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
NSN.J. Simmonds
N.J. Simmonds
SMS.J. MacNeill
S.J. MacNeill
PCP. Cullinan
P. Cullinan
MHM.E. Hodson
M.E. Hodson
The clinical course of patients with cystic fibrosis (CF) is variable and probably determined by many interacting factors. We aimed to examine the influence of early social and clinical factors on long-term survival.A case–control study of adult CF patients was used to compare long-term survivors (aged ≥40 yrs) with patients who died before reaching 30 yrs of age. Each case (n = 78) was matched by birth date with at least one control (n = 152), after exclusion of “late diagnosis” patients. Probability-weighted logistic regression models were used to identify influences on survival.Factors resulting in increased probabilities of survival included high body mass index (OR 1.76, 95% CI 1.40–2.22), forced expiratory volume in 1 s (OR per 5% increase 1.54, 95% CI 1.32–1.80), and forced vital capacity (OR per 5% increase 1.54, 95% CI 1.33–1.78) at transfer to the adult clinic and the exclusive use of oral antibiotics (OR 8.31, 95% CI 3.02–22.88). Factors resulting in decreased probabilities of survival werePseudomonas aeruginosaacquisition (OR 0.18, 95% 0.05–0.65) or pneumothorax before transfer to the adult clinic (OR 0.02, 95% CI 0.004–0.08) and referral from a paediatric clinic in a deprived area (OR 0.13, 95% CI 0.04–0.38).Long-term survival is associated with the clinical features present by the time of referral to an adult clinic. Even “early-diagnosis” disease appears to have different phenotypes, possibly independent of CF gene function, that have different survival patterns.

27 September 2023 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
CCCarlo Castellani
Carlo Castellani
NSNicholas J Simmonds
Nicholas J Simmonds
JBJürg Barben
Jürg Barben
CACharlotte Addy
Charlotte Addy
ABAmanda Bevan
Amanda Bevan
KSKevin Southern
Kevin Southern

1 May 2013 in Paediatric Respiratory Reviews
Verified
Journal Article
Closed access
NSN.J. Simmonds
N.J. Simmonds

19 March 2024 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
NSN.J. Simmonds
N.J. Simmonds
KSKevin Southern
Kevin Southern
EWE. De Wachter
E. De Wachter
KBK. De Boeck
K. De Boeck
FBF. Bodewes
F. Bodewes
CCCarlo Castellani
Carlo Castellani